Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sareh Etemad

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Case Reports|December 8, 2025
Recurrent Spinal Hydatid Cyst: A Histopathologic Case ReportSareh Etemad, Golnaz Ghayyem Hassankhani
Iranian Journal of Pathology|May 27, 2026
Thyroid Collision Carcinoma: A Case ReportZahra Miri, Sareh Etemad, Golnaz Ghayyem Hassankhani, et al.
Molecular Biotechnology|December 9, 2025
Investigation of Transcriptome and Kinome in Non Metastatic and Metastatic Renal Clear Cancer Stem Cells and Their Relationship with Gut MicrobiotaEhsan Alimoradi, Mohammad Amin Hashemnejad, Sareh Etemad, et al.
Iranian Journal of Public Health|October 21, 2024
Evaluation of Genes and Molecular Pathways Involved in Pathogenesis of Sickle Cell Anemia: A Bioinformatics Analysis and Future PerspectiveReza Maddah, Sareh Etemad, Bahareh Shateri Amiri, et al.
American Journal of Stem Cells|November 24, 2025
Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: a pilot clinical trialRamin Raoufinia, Jalil Tavakol-Afshari, Mozhgan Afkhamizadeh, et al.
Journal of Research in Health Sciences|October 21, 2024
Prevalence of Human Papillomavirus (HPV) Infection and its Association With Pap Smear Findings Among Women Attending a Gynecology Clinic in Khorasan Razavi-IranSareh Etemad, Amir Mohammad Asghari Baghalan, Bita Naeimi, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 11, 2026
Interaction of HIF-1a with various cell death pathways in tumor immune microenvironment (TIME)Mahsa Manafi Varkiani, Ferdos Faghihkhorasani, Mona Moosavi, et al.
British Journal of Pharmacology|October 12, 2024
Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasomeNazanin Pazhouhesh Far, Mahsa Hajiheidari Varnousafaderani, Ferdos Faghihkhorasani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Case Reports|December 8, 2025
Recurrent Spinal Hydatid Cyst: A Histopathologic Case ReportSareh Etemad, Golnaz Ghayyem Hassankhani
Iranian Journal of Pathology|May 27, 2026
Thyroid Collision Carcinoma: A Case ReportZahra Miri, Sareh Etemad, Golnaz Ghayyem Hassankhani, et al.
Molecular Biotechnology|December 9, 2025
Investigation of Transcriptome and Kinome in Non Metastatic and Metastatic Renal Clear Cancer Stem Cells and Their Relationship with Gut MicrobiotaEhsan Alimoradi, Mohammad Amin Hashemnejad, Sareh Etemad, et al.
Iranian Journal of Public Health|October 21, 2024
Evaluation of Genes and Molecular Pathways Involved in Pathogenesis of Sickle Cell Anemia: A Bioinformatics Analysis and Future PerspectiveReza Maddah, Sareh Etemad, Bahareh Shateri Amiri, et al.
American Journal of Stem Cells|November 24, 2025
Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: a pilot clinical trialRamin Raoufinia, Jalil Tavakol-Afshari, Mozhgan Afkhamizadeh, et al.
Journal of Research in Health Sciences|October 21, 2024
Prevalence of Human Papillomavirus (HPV) Infection and its Association With Pap Smear Findings Among Women Attending a Gynecology Clinic in Khorasan Razavi-IranSareh Etemad, Amir Mohammad Asghari Baghalan, Bita Naeimi, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 11, 2026
Interaction of HIF-1a with various cell death pathways in tumor immune microenvironment (TIME)Mahsa Manafi Varkiani, Ferdos Faghihkhorasani, Mona Moosavi, et al.
British Journal of Pharmacology|October 12, 2024
Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasomeNazanin Pazhouhesh Far, Mahsa Hajiheidari Varnousafaderani, Ferdos Faghihkhorasani, et al.
Pageof 1